Sign in

CIK 0001787400

  • Non-accelerated filer
  • Smaller reporting company

Nkarta, Inc.

Sign in to watch
Ticker
NKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474515206
Phone
+1 925-407-1049
Business address
1150 VETERANS BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-01-14 Mahmood Nadir Exercise or conversion +3,083 $3.89 $12K 31,488
2021-01-14 Mahmood Nadir Exercise or conversion · Stock Option (right to buy) −3,083 49,322
2021-01-08 Rajangam Kanya Chief Medical Officer Grant or award · Stock Option (right to buy) +52,500 52,500
2021-01-08 HASTINGS PAUL J Chief Executive Officer Grant or award · Stock Option (right to buy) +157,500 157,500
2021-01-08 Mahmood Nadir Grant or award · Stock Option (right to buy) +52,500 52,500
2021-01-08 Hager Alicia J. Chief Legal Officer Grant or award · Stock Option (right to buy) +13,125 13,125
2021-01-08 Trager James Chief Scientific Officer Grant or award · Stock Option (right to buy) +52,500 52,500
2020-12-03 Mahmood Nadir Exercise or conversion +3,000 $3.89 $12K 28,405
2020-12-03 Mahmood Nadir Exercise or conversion · Stock Option (right to buy) −3,000 52,405
2020-10-26 Hager Alicia J. Chief Legal Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2020-10-02 Mahmood Nadir Grant or award · Stock Option (right to buy) +50,000 50,000
2020-10-02 Mahmood Nadir Grant or award · Stock Option (right to buy) +50,000 50,000
2020-07-14 GLAXOSMITHKLINE PLC Director Conversion +79,090 79,090
2020-07-14 GLAXOSMITHKLINE PLC Director Conversion +525,499 604,589
2020-07-14 GLAXOSMITHKLINE PLC Director Conversion +1,712,810 2,317,399
2020-07-14 GLAXOSMITHKLINE PLC Director Purchase +833,333 $18.00 $15.0M 3,150,732
2020-07-14 GLAXOSMITHKLINE PLC Director Conversion · Series A Preferred Stock −292,663 0
2020-07-14 GLAXOSMITHKLINE PLC Director Conversion · Series A Preferred Stock −1,994,348 0
2020-07-14 GLAXOSMITHKLINE PLC Director Conversion · Series B Preferred Stock −6,337,403 0
2020-07-14 GLAXOSMITHKLINE PLC Director Grant or award · Stock Option (right to buy) +10,700 10,700

Page 15 of 19 · 364 trades